Cell Surface Functionalization with Heparin‐Conjugated Lipid to Suppress Blood Activation
- 20 January 2021
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 31 (11)
- https://doi.org/10.1002/adfm.202008167
Abstract
No abstract availableFunding Information
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
This publication has 38 references indexed in Scilit:
- Glycocalyx Degradation in Ischemia-Reperfusion InjuryThe American Journal of Pathology, 2020
- Hemorrhagic shock drives glycocalyx, barrier and organ dysfunction early after polytraumaJournal of Critical Care, 2018
- Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: A critical reviewJournal of Autoimmunity, 2015
- Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatmentWorld Journal of Transplantation, 2015
- Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injuryFree Radical Biology & Medicine, 2012
- Glycosylation in Cellular Mechanisms of Health and DiseaseCell, 2006
- Mechanotransduction and the glycocalyxJournal of Internal Medicine, 2006
- A Genetic Approach to Mammalian Glycan FunctionAnnual Review of Biochemistry, 2003
- The Endothelial Glycocalyx Protects Against Myocardial EdemaCirculation Research, 2003
- Protein glycosylationJBIC Journal of Biological Inorganic Chemistry, 1993